Comparison of Treatment Safety and Patient Survival in Elderly versus Nonelderly Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib Combined with Transarterial Chemoembolization: A Propensity Score Matching Study

AIMS: This retrospective study was carried out to compare the outcomes between elderly (≥70 years of age) and nonelderly patients (<70 years of age) with advanced hepatocellular carcinoma (HCC) who received sorafenib combined with transarterial chemoembolization (TACE). METHODS: 88 patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Hao, Duan, Zhenhua, Long, Xiaoran, Hertzanu, Yancu, Tong, Xiaoqiang, Xu, Xiaoquan, Shi, Haibin, Liu, Sheng, Yang, Zhengqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4331363/
https://www.ncbi.nlm.nih.gov/pubmed/25689846
http://dx.doi.org/10.1371/journal.pone.0117168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4331363/
https://www.ncbi.nlm.nih.gov/pubmed/25689846
http://dx.doi.org/10.1371/journal.pone.0117168

Ejemplares similares